Unibest

Pharmaceutical intermediates

KT-474 Intermediates

2 pharmaceutical intermediates for KT-474. Indication: Atopic Dermatitis; Hidradenitis Suppurativa.

提交项目All intermediates

About KT-474

Originator
Kymera Therapeutics, Inc.
Indication
Atopic Dermatitis; Hidradenitis Suppurativa

Available intermediates

2 intermediates currently listed for KT-474. Request specifications, documentation or a quotation for any item below.

KT-474 intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate1224944-77-7//
3-(4-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione2304754-51-4//

Other programs under K

Ketorolac tromethamineKetotifen fumarate

Building toward KT-474?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →